Description

CJC-1295 (No DAC) – Research Peptide

CJC-1295 (without DAC) is a synthetic peptide commonly used in laboratory settings to study growth hormone–releasing hormone (GHRH) receptor signaling and peptide pharmacokinetics. Unlike its DAC-modified counterpart, this version is designed without the Drug Affinity Complex, resulting in a shorter activity window, making it useful in controlled research environments where shorter peptide exposure and pulse-based signaling are being evaluated.

Researchers frequently reference CJC-1295 without DAC in studies exploring growth hormone regulatory pathways, peptide receptor interactions, and endocrine signaling models. Its shorter duration profile allows investigators to observe more immediate peptide activity dynamics within experimental systems.

Key Research Characteristics

• Synthetic analog of growth hormone–releasing hormone (GHRH)

• Formulated without Drug Affinity Complex (DAC) for shorter activity duration in research models

• Commonly studied in peptide signaling and endocrine pathway research

• Supplied in lyophilized (freeze-dried) form for laboratory handling and storage

• Intended strictly for in-vitro and laboratory research applications

Important Notice

This product is sold for research purposes only and is not intended for human or animal consumption, medical use, or therapeutic application. No claims are made regarding safety, efficacy, or potential outcomes. Purchasers are responsible for proper handling and use in accordance with applicable regulations and laboratory standards.